Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer. - Soulie,P.; Trandafir,L.; Taama,A. (Anti-Cancer Drugs, 1997)